Miracle Mile Advisors’s Biogen BIIB Stock Holding History

Miracle Mile Advisors’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$307K	Buy	1,421 +44	+3%	+$8.42K	﹤0.01%	796
2026 Q1	$252K	Buy	1,377 +109	+9%	+$20.1K	﹤0.01%	781
2025 Q4	$223K	Buy	+1,268	New	+$207K	﹤0.01%	811
2025 Q3	–	Sell	-9,594	Closed	-$1.2M	–	828
2025 Q2	$1.2M	Buy	+9,594	New	+$1.2M	0.02%	338
2023 Q3	–	Sell	-769	Closed	-$219K	–	485
2023 Q2	$219K	Buy	769 +25	+3%	+$7.44K	0.01%	464
2023 Q1	$207K	Hold	744	–	–	0.01%	478
2022 Q4	$206K	Buy	+744	New	+$210K	0.01%	469
2021 Q4	–	Sell	-744	Closed	-$211K	–	448
2021 Q3	$211K	Sell	744 -42	-5%	-$13.8K	0.01%	395
2021 Q2	$272K	Sell	786 -223	-22%	-$67.6K	0.01%	326
2021 Q1	$282K	Sell	1,009 -7	-0.7%	-$1.89K	0.02%	324
2020 Q4	$249K	Hold	1,016	–	–	0.02%	328
2020 Q3	$288K	Sell	1,016 -3,007	-75%	-$839K	0.02%	295
2020 Q2	$1.08M	Buy	+4,023	New	+$1.21M	0.09%	172
2015 Q3	–	Sell	-623	Closed	-$252K	–	59
2015 Q2	$252K	Buy	+623	New	+$250K	0.17%	32

Other funds holding BIIB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Miracle Mile Advisors's BIIB Position: Q2 2026 in Review

Miracle Mile Advisors increased its Biogen (BIIB) stake by 3.2% in Q2 2026, buying an estimated $8.42K and bringing the position to 1,421 shares worth $307K. The position accounts for ﹤0.01% of the portfolio, ranked #796.

Miracle Mile Advisors first reported a position in BIIB in Q2 2015 and has held it in 14 quarters since. The position peaked at $1.2M in Q2 2025. 1,043 funds tracked by Wall St. Rank hold BIIB as of Q2 2026.

Miracle Mile Advisors held 1,421 shares of Biogen worth $307K as of Q2 2026.
Miracle Mile Advisors bought 44 Biogen shares in Q2 2026, an estimated $8.42K.
Biogen made up ﹤0.01% of Miracle Mile Advisors's portfolio in Q2 2026, its #796 holding.
Miracle Mile Advisors first reported a position in Biogen in Q2 2015 and has held it in 14 quarters since.
Miracle Mile Advisors's Biogen position peaked at $1.2M in Q2 2025.
1,043 funds tracked by Wall St. Rank held Biogen as of Q2 2026.

Based on Miracle Mile Advisors's 13F filing for Q2 2026, filed 22 Jul 2026.